AAP updates guidelines on palivizumab to prevent RSV

09/18/2009 | Medscape (free registration)

AAP published updated recommendations in Pediatrics on immunoprophylaxis using palivizumab to prevent serious respiratory syncytial virus disease in high risk children. The updates for starting and stopping prophylaxis were based on CDC descriptions of RSV seasonality in areas throughout the U.S.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX